Bianca Rivera-Peña

ORCID: 0000-0001-8821-0210
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myeloid Leukemia Research
  • Genetic and phenotypic traits in livestock
  • Epigenetics and DNA Methylation
  • Genetic Mapping and Diversity in Plants and Animals
  • Meat and Animal Product Quality
  • Synthesis and biological activity
  • Retinoids in leukemia and cellular processes
  • Blood disorders and treatments
  • Plant Taxonomy and Phylogenetics
  • Animal Behavior and Welfare Studies
  • TGF-β signaling in diseases
  • Immune cells in cancer
  • Immune Response and Inflammation
  • Cervical Cancer and HPV Research
  • Inflammasome and immune disorders
  • Protein Degradation and Inhibitors
  • Cleft Lip and Palate Research
  • Rabbits: Nutrition, Reproduction, Health
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Acute Lymphoblastic Leukemia research

Albert Einstein College of Medicine
2019-2024

Sidney Kimmel Comprehensive Cancer Center
2023

Johns Hopkins University
2023

The University of Texas MD Anderson Cancer Center
2023

Montefiore Medical Center
2019-2021

University of Puerto Rico at Río Piedras
2016

Institut National de la Recherche Agronomique
2006-2011

Département Biologie et Amélioration des Plantes
2010

University of Puerto Rico System
2010

Abstract The BCL2-inhibitor, Venetoclax (VEN), has shown significant anti-leukemic efficacy in combination with the DNMT-inhibitor, Azacytidine (AZA). To explore mechanisms underlying selective sensitivity of mutant leukemia cells to VEN and AZA, we used cell-based isogenic models containing a common leukemia-associated mutation epigenetic regulator ASXL1 . KBM5 CRISPR/Cas9-mediated correction G710X showed reduced leukemic growth, increased myeloid differentiation, decreased HOXA BCL2 gene...

10.1038/s41408-021-00541-0 article EN cc-by Blood Cancer Journal 2021-09-21

Summary Although the European rabbit ( Oryctolagus cuniculus ) is used both in agronomics and research, genomic resources for this species are still limited no microsatellite‐based genetic map has been reported. Our aim was to construct a with cytogenetically mapped microsatellites so as build an integrated cytogenetic map. A reference population of 187 rabbits comprising eight three‐generation families 10–25 offspring per family produced. One hundred ninety‐four 305 previously identified...

10.1111/j.1365-2052.2006.01462.x article EN Animal Genetics 2006-06-06

Acute myeloid leukemia (AML) is an aggressive hematologic malignancy that continues to have poor prognosis despite recent therapeutic advances. Venetoclax (Ven), a BCL2-inhibitor has shown high response rate in AML; however, relapse invariable due mitochondrial dysregulation includes upregulation of the antiapoptotic protein MCL1, central mechanism Ven resistance (Ven-res). We previously demonstrated transcription factor STAT3 upregulated AML hematopoietic stem and progenitor cells (HSPCs)...

10.1101/2024.08.05.599788 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2024-08-07

HPV-16 modifies the overall survival (OS) of patients with oropharyngeal cancer (OPSCC). has been established as risk factor for OPSCC, but infection may also reside in larynx and oral cavity. We evaluated status on OS Head Neck Squamous Cell Carcinoma (HNSCC) patients.HPV-16 was confirmed by amplification E6 E7 viral oncogenes through PCR assay IHC 185 HNSCC samples. Associations between clinicopathological parameters were performed using Fisher's exact test x(2). Survival analysis...

10.1186/s13027-016-0095-4 article EN cc-by Infectious Agents and Cancer 2016-08-05

Overactivation of the Transforming Growth Factor Beta (TGF-β) pathway is implicated in pathogenesis cytopenias Myelodysplastic syndromes (MDS) and Acute Myeloid Leukemia (AML). IOA-359 IOA-360 are potent small molecule inhibitors TGF-beta Receptor type I kinase (TGF-βRI, also referred to as ALK5, activin receptor-like 5) that abrogate SMAD phosphorylation hematopoietic cell lines. Both were able inhibit TGF-β mediated gene transcription at specific doses. ALK5 abrogated growth inhibitory...

10.1080/10428194.2024.2444479 article EN Leukemia & lymphoma/Leukemia and lymphoma 2024-12-27

Abstract Gene polymorphism has been found to be associated with the susceptibility cancer or its severity as exemplified in CDKN2A gene. regulates G1 arrest and plays an important role head neck (HNSCC) carcinogenesis. Deregulated tumor expression of previously described association HNSCC clinical progression. Aberrant methylation is common gene silencing mechanism HNSCC. polymorphic, variant alleles G/A442, C/T 540, C/G 500 cancer. Previously we have shown that Puerto Rican population G/A...

10.1158/1538-7445.am10-2839 article EN Cancer Research 2010-04-01
Coming Soon ...